[目的] 探讨ghrelin对蒙古绵羊脐静脉内皮细胞的血管内皮生长因子VEGF及其受体Flt-1 mRNA表达的影响.[方法] 试验分为4组: I组,空白对照组;II组,脂质体组(不加寡核苷酸);III组(SCON),20 μmol/L正义寡核苷酸组;IV组(ASCON),20 μmol/L反义寡核苷酸组.上述各组均在培养24、36、48 h后,采用实时荧光定量方法检测VEGF及其受体Flt-1 mRNA表达情况的变化.[结果] VEGF和Flt-1熔解曲线表明扩增效果好,培养24 h, VEGF mRNA I组相对表达量为0.076 9,II组为0.076 8,III组为0.076 9,3组之间无显著性差异(P>0.05),IV组VEGF mRNA 相对表达量下降为0.024 2,且与I、II、III组有显著性差异(P<0.05).培养36 h,前3组相对表达量分别为0.059,0.051,0.051 4,3组之间无显著性差异(P>0.05),第IV组为0.024 2,与前3组比较有显著性差异(P<0.05).培养48 h,前3组相对表达量分别为0.061,0.055 2,0.052 1,3组之间无显著性差异(P<0.05),第IV组为0.011 5,与前3组比较有显著性差异(P<0.05).培养24 h,Flt-1 mRNA I组相对表达量为0.078 6;II组为0.078 2,III组为0.078 1, 3组之间无显著性差异(P>0.05),IV组Flt-1 mRNA 相对表达量下降为0.025 6,且与I、II、III组有显著性差异(P<0.05).培养36 h,前3组相对表达量分别为0.078 1,0.078 4,0.078 2,3组之间无显著性差异(P>0.05),第IV组为0.022 8,与前3组比较有显著性差异(P<0.05).培养48 h,前3组相对表达量分别为0.069 1,0.078 0,0.069 3,3组之间无显著性差异(P>0.05),第IV组为0.021 5,与前3组比较有显著性差异(P<0.05).可见,VEGF受体Flt-1mRNA的表达与VEGF相似.二者均在 I组、II组表达量无差异,具有较高的表达量,随着时间的延长没有明显变化;在III组表达轻微下降,但与I组和II组无显著性差异(P>0.05);IV组的表达量显著下降(P<0.05),并且随着时间的延长至逐渐下降.[结论] 反义抑制ghrelin对VEGF及其受体Flt-1的mRNA表达有下调作用.
[目的] 探討ghrelin對矇古綿羊臍靜脈內皮細胞的血管內皮生長因子VEGF及其受體Flt-1 mRNA錶達的影響.[方法] 試驗分為4組: I組,空白對照組;II組,脂質體組(不加寡覈苷痠);III組(SCON),20 μmol/L正義寡覈苷痠組;IV組(ASCON),20 μmol/L反義寡覈苷痠組.上述各組均在培養24、36、48 h後,採用實時熒光定量方法檢測VEGF及其受體Flt-1 mRNA錶達情況的變化.[結果] VEGF和Flt-1鎔解麯線錶明擴增效果好,培養24 h, VEGF mRNA I組相對錶達量為0.076 9,II組為0.076 8,III組為0.076 9,3組之間無顯著性差異(P>0.05),IV組VEGF mRNA 相對錶達量下降為0.024 2,且與I、II、III組有顯著性差異(P<0.05).培養36 h,前3組相對錶達量分彆為0.059,0.051,0.051 4,3組之間無顯著性差異(P>0.05),第IV組為0.024 2,與前3組比較有顯著性差異(P<0.05).培養48 h,前3組相對錶達量分彆為0.061,0.055 2,0.052 1,3組之間無顯著性差異(P<0.05),第IV組為0.011 5,與前3組比較有顯著性差異(P<0.05).培養24 h,Flt-1 mRNA I組相對錶達量為0.078 6;II組為0.078 2,III組為0.078 1, 3組之間無顯著性差異(P>0.05),IV組Flt-1 mRNA 相對錶達量下降為0.025 6,且與I、II、III組有顯著性差異(P<0.05).培養36 h,前3組相對錶達量分彆為0.078 1,0.078 4,0.078 2,3組之間無顯著性差異(P>0.05),第IV組為0.022 8,與前3組比較有顯著性差異(P<0.05).培養48 h,前3組相對錶達量分彆為0.069 1,0.078 0,0.069 3,3組之間無顯著性差異(P>0.05),第IV組為0.021 5,與前3組比較有顯著性差異(P<0.05).可見,VEGF受體Flt-1mRNA的錶達與VEGF相似.二者均在 I組、II組錶達量無差異,具有較高的錶達量,隨著時間的延長沒有明顯變化;在III組錶達輕微下降,但與I組和II組無顯著性差異(P>0.05);IV組的錶達量顯著下降(P<0.05),併且隨著時間的延長至逐漸下降.[結論] 反義抑製ghrelin對VEGF及其受體Flt-1的mRNA錶達有下調作用.
[목적] 탐토ghrelin대몽고면양제정맥내피세포적혈관내피생장인자VEGF급기수체Flt-1 mRNA표체적영향.[방법] 시험분위4조: I조,공백대조조;II조,지질체조(불가과핵감산);III조(SCON),20 μmol/L정의과핵감산조;IV조(ASCON),20 μmol/L반의과핵감산조.상술각조균재배양24、36、48 h후,채용실시형광정량방법검측VEGF급기수체Flt-1 mRNA표체정황적변화.[결과] VEGF화Flt-1용해곡선표명확증효과호,배양24 h, VEGF mRNA I조상대표체량위0.076 9,II조위0.076 8,III조위0.076 9,3조지간무현저성차이(P>0.05),IV조VEGF mRNA 상대표체량하강위0.024 2,차여I、II、III조유현저성차이(P<0.05).배양36 h,전3조상대표체량분별위0.059,0.051,0.051 4,3조지간무현저성차이(P>0.05),제IV조위0.024 2,여전3조비교유현저성차이(P<0.05).배양48 h,전3조상대표체량분별위0.061,0.055 2,0.052 1,3조지간무현저성차이(P<0.05),제IV조위0.011 5,여전3조비교유현저성차이(P<0.05).배양24 h,Flt-1 mRNA I조상대표체량위0.078 6;II조위0.078 2,III조위0.078 1, 3조지간무현저성차이(P>0.05),IV조Flt-1 mRNA 상대표체량하강위0.025 6,차여I、II、III조유현저성차이(P<0.05).배양36 h,전3조상대표체량분별위0.078 1,0.078 4,0.078 2,3조지간무현저성차이(P>0.05),제IV조위0.022 8,여전3조비교유현저성차이(P<0.05).배양48 h,전3조상대표체량분별위0.069 1,0.078 0,0.069 3,3조지간무현저성차이(P>0.05),제IV조위0.021 5,여전3조비교유현저성차이(P<0.05).가견,VEGF수체Flt-1mRNA적표체여VEGF상사.이자균재 I조、II조표체량무차이,구유교고적표체량,수착시간적연장몰유명현변화;재III조표체경미하강,단여I조화II조무현저성차이(P>0.05);IV조적표체량현저하강(P<0.05),병차수착시간적연장지축점하강.[결론] 반의억제ghrelin대VEGF급기수체Flt-1적mRNA표체유하조작용.
[Objective] This study was to investigate the effect of VEGF and its receptor Flt-1 mRNA expression in Mongolia sheep umbilical vein endothelial cells by ghrelin antisense inhibition. [Method] Experiments were divided into 4 groups: group I (blank control group); group II (liposome group); group III (SCON group: 20 μmol/L sense oligonucleotide); group IV (ASCON: 20 μmol/L antisense oligonucleotide). VEGF and its receptor Flt-1 mRNA expression changes were detected by using real-time fluorescence quantitative detection after 24, 36 and 48 h. [Result] The expression of VEGF mRNA in group I, group II were insignificantly different at higher expression levels, and did not change significantly with the time; the expression of VEGF mRNA in group III assumed a slight decrease, but there were no significant differences between group I and group II (P>0.05), the expression of VEGF mRNA in group IV(antisense oligonucleotide group ) decreased significantly (P< 0.05); the expression of VEGF receptor FLT-1 mRNA was similar to that of VEGF. [Conclusion] Antisense inhibition ghrelin has a downward effect to the expression of VEGF and its receptor Flt-1 the mRNA.